Close Menu

Blind No More?

FDA has given biotech company Advanced Cell Technology the go-ahead to test a treatment for macular degeneration using human embryonic stem cells in a clinical trial, says Jennifer Welsh at the 80beats blog. Researchers at Advanced Cell Technology suggest that implanting hESCs in these patients could end retinal pigment epithelial cell death and reverse blindness; using this approach, the team saw improved vision in rats, Welsh says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.